Diatrizoate Meglumine
Prescription品牌名称: Cystografin
About This Medication
DESCRIPTION Cystografin is a radiopaque contrast agent supplied as a sterile, clear, colorless to pale yellow, mobile or slightly viscous solution. Each mL provides 300 mg diatrizoate meglumine with 0.4 mg edetate disodium as a sequestering agent. Each mL of solution also contains approximately 141 mg organically bound iodine. At the time of manufacture, the air in the container is replaced by nitrogen. The preparation should be protected from strong light.
活性成分
| 成分 | 规格 |
|---|---|
| Diatrizoate Meglumine | - |
适应证与用法
用法用量
Side Effects Overview
警告与注意事项
WARNINGS Severe sensitivity reactions are more likely to occur in patients with a personal or family history of bronchial asthma, significant allergies, or previous reactions to contrast agents. A history of sensitivity to iodine per se or to other contrast agents is not an absolute contraindication to the use of diatrizoate meglumine, but calls for extreme caution in administration.
禁忌证
CONTRAINDICATIONS This preparation is contraindicated in patients with a hypersensitivity to salts of diatrizoic acid.
Frequently Asked Questions
INDICATION Cystografin is indicated for retrograde cystourethrography.
DOSAGE AND ADMINISTRATION Preparation of the patient: Appropriate preparation is desirable for optimal results. A laxative the night before the examination and a low residue diet the day before the procedure are recommended. Dosage: The dose for retrograde use in cystography and voiding cystourethrography ranges from 25 to 300 mL depending on the age of the patient and the degree of bladder irritability; amounts greater than 300 mL may be used if the bladder capacity allows. Best results are obtained …
WARNINGS Severe sensitivity reactions are more likely to occur in patients with a personal or family history of bronchial asthma, significant allergies, or previous reactions to contrast agents. A history of sensitivity to iodine per se or to other contrast agents is not an absolute contraindication to the use of diatrizoate meglumine, but calls for extreme caution in administration.
CONTRAINDICATIONS This preparation is contraindicated in patients with a hypersensitivity to salts of diatrizoic acid.
Diatrizoate Meglumine is a prescription medication. You will need a valid prescription from a licensed healthcare provider.
Similar Injection Products
Browse all Injection products →References & Data Sources
- • DailyMed — Diatrizoate Meglumine drug label (National Library of Medicine)
- • openFDA — Diatrizoate Meglumine label data (U.S. Food & Drug Administration)
- • NDC Directory — Diatrizoate Meglumine (FDA National Drug Code)
医疗免责声明
本页面信息仅供教育参考之用,不得用于替代专业医疗建议、诊断或治疗。
如有任何关于病症或药物的疑问,请务必咨询您的医生或其他具有资质的医疗保健提供者。
数据来源: DailyMed (NLM), openFDA, MFDS